Management of nasopharyngeal carcinoma: current practice and future perspective
Nasopharyngeal carcinoma of the undifferentiated subtype is endemic to southern China,
and patient prognosis has improved significantly over the past three decades because of …
and patient prognosis has improved significantly over the past three decades because of …
Cell-free nucleic acids as biomarkers in cancer patients
DNA, mRNA and microRNA are released and circulate in the blood of cancer patients.
Changes in the levels of circulating nucleic acids have been associated with tumour burden …
Changes in the levels of circulating nucleic acids have been associated with tumour burden …
[HTML][HTML] Analysis of plasma Epstein–Barr virus DNA to screen for nasopharyngeal cancer
Background Circulating cell-free Epstein–Barr virus (EBV) DNA is a biomarker for
nasopharyngeal carcinoma. We conducted a prospective study to investigate whether EBV …
nasopharyngeal carcinoma. We conducted a prospective study to investigate whether EBV …
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Bossi, AT Chan, L Licitra, A Trama… - Annals of …, 2021 - annalsofoncology.org
Nasopharyngeal carcinoma (NPC) is a disease with unique epidemiological features. The
distribution of the disease demonstrates a clear regional, racial and gender prevalence. In …
distribution of the disease demonstrates a clear regional, racial and gender prevalence. In …
Prognostic value of deep learning PET/CT-based radiomics: potential role for future individual induction chemotherapy in advanced nasopharyngeal carcinoma
Purpose: We aimed to evaluate the value of deep learning on positron emission tomography
with computed tomography (PET/CT)–based radiomics for individual induction …
with computed tomography (PET/CT)–based radiomics for individual induction …
Analysis of plasma Epstein-Barr virus DNA in nasopharyngeal cancer after chemoradiation to identify high-risk patients for adjuvant chemotherapy: a randomized …
Purpose The contribution of adjuvant chemotherapy after chemoradiation therapy (CRT) in
nasopharyngeal cancer (NPC) remains controversial. Plasma Epstein-Barr virus (EBV) DNA …
nasopharyngeal cancer (NPC) remains controversial. Plasma Epstein-Barr virus (EBV) DNA …
Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma
LQ Tang, CF Li, J Li, WH Chen, QY Chen… - Journal of the …, 2016 - academic.oup.com
Background: This study aimed to establish an effective prognostic nomogram with or without
plasma Epstein-Barr virus DNA (EBV DNA) for nondisseminated nasopharyngeal carcinoma …
plasma Epstein-Barr virus DNA (EBV DNA) for nondisseminated nasopharyngeal carcinoma …
[HTML][HTML] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced …
SM Cao, Q Yang, L Guo, HQ Mai, HY Mo… - European journal of …, 2017 - Elsevier
Background The role of neoadjuvant chemotherapy (NACT) for locoregionally advanced
nasopharyngeal carcinoma (NPC) is unclear. We aimed to evaluate the feasibility and …
nasopharyngeal carcinoma (NPC) is unclear. We aimed to evaluate the feasibility and …
[图书][B] Pathology and genetics of head and neck tumours
L Barnes - 2005 - books.google.com
Pathology and Genetics of Head and Neck Tumoursis the latest volume in the new WHO
series, on histological and genetic typing of human tumours. This authoritative, concise …
series, on histological and genetic typing of human tumours. This authoritative, concise …
Epstein–Barr virus: 40 years on
LS Young, AB Rickinson - Nature Reviews Cancer, 2004 - nature.com
Epstein–Barr virus (EBV) was discovered 40 years ago from examining electron
micrographs of cells cultured from Burkitt's lymphoma, a childhood tumour that is common in …
micrographs of cells cultured from Burkitt's lymphoma, a childhood tumour that is common in …